Mumbai: There seemed no light at end of the long dark tunnel for parents of Sushant, an engineering student, inflicted with Multiple Sclerosis, a debilitating incurable disease. Despairing, they were left to pin their hopes only on some miracle, which surprisingly awaited them in StemRx Bio Science Solutions, a state of art lab nestled in Aishwarya Rai Bachhan fame hospital SevenHills.
‘Miracle’ may be a word which is not endorsed by modern medicine. But there is no other way one can describe what stem cell therapy did to Sushant. Miracles as this are multiplying in StemRx, thanks to Dr Pradeep Mahajan, an ace regenerative medicine and stem cell specialist.
Sushant, who could not speak, walk, nor could move any part of the body, turned a new leaf. He had come on the back of his father but went back walking. Eyam (from Nairobi), a neuro- trauma patient and being comatose for seven years, found his sense and legs here. The list is long and has reached over 2000 in number in his 4 years of practice.
Talking to Medicare News, Dr Mahajan, a trained medical doctor (MS) and Chairman and Managing Director, StemRx said, ‘we have almost banished the word ‘impossible’ from dictionary of diseases. We have succeeded in treating patients suffering from all kinds of incurable diseases for which mainstream medicine does not have any solution. The impossible diseases which we have been treating successfully include Cerebral Palsy, Multiple Sclerosis, Ankylosing Spondylitis, Type 1 Diabetes, Rheumatoid Arthritis, autism, Down’s syndrome, Paraplegia et al. Our stem cell products are derived from body of the patients, so side effects are almost nonexistent.’
He has also developed stem cell protocols for anti ageing and has anti ageing solutions for head to toe. He is also the vice president of Anti Ageing Foundation. Talking to Medicare News, Dr Prabhu Mishra, President, Anti Ageing Foundation and a stem cell scientist, said, ‘ There is no doubt anymore that regenerative medicine based on stem cells is proving game changer in healthcare. New rules rhave come. Regulators have given clear view on all stem cell products and categorised them as drugs. In view of this development, definite clinical trials and pilot studies are need of the hour to firm up this therapy. Ethical component will have to be fiercely guarded.’
